FDA Center for Drug Evaluation & Research Acting Director Corrigan-Curay Testifies Before Senate Health Committee
June 10, 2025
June 10, 2025
WASHINGTON, June 10 -- The Senate Health, Education, Labor and Pensions Committee released the following testimony by Jacqueline Corrigan-Curay, acting director of the Center for Drug Evaluation and Research at the Food and Drug Administration, from a June 4, 2025, hearing entitled "Reauthorization of the Over-the-Counter Monograph Drug User Fee Program":
* * *
Chair Cassidy, Ranking Member Sanders, and Members of the Committee, thank you for the opportunity t . . .
* * *
Chair Cassidy, Ranking Member Sanders, and Members of the Committee, thank you for the opportunity t . . .